GovChime
Notice ID: c44524dd912c4963a119b8ceb37548efCombined Synopsis/Solicitation

Portfolio Impact Analysis for the Therapeutic Development Branch (TDB), NCATS

Archived on September 30, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
2:00 PM UTC−04:00
Posted
September 11, 2024
Notice type
Combined Synopsis/Solicitation
Set-aside
SBA Certified Women-Owned Small Business (WOSB) Program Set-Aside (FAR 19.15)
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Sep 9, 2025

Identifiers

Solicitation number
75N95024Q00564
Notice ID
c44524dd912c4963a119b8ceb37548ef

Description

Amendment 1 (9/11/2024): Adding Q&A as an attachment to the solicitation. See attached. The Therapeutic Development Branch (TDB) in the intramural Division of Preclinical Innovation (DPI) at the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH) was established to enable preclinical development through collaborative partnerships. In alignment with accomplishing the Centers mission, the Branch needs to conduct a portfolio impact analysis, from its inception in 2010 to present. The goal is to capture key metrics and evaluate the programs research outcomes, including analyzing the economic and other quantitative and qualitative impact measures on further research and development and healthcare. TDB requires the expertise of a firm capable of conducting such types of specialized impact analyses of novel therapeutics and related technologies. The results of this analysis will be used by Branch leadership to inform future research policy and priorities. See the attached Combined Synopsis/Solicitation, Statement of Work, and other attachments for complete requirement details.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N95024Q00564
  1. Combined Synopsis
  1. 2×
    Combined SynopsisCurrentSep 5, 2024

    Portfolio Impact Analysis for the Therapeutic Development Branch (TDB), NCATS

    Notice c44524dd912c4963a119b8ceb37548ef on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95024Q00564

Archive Date

Sep 30, 2024

Office Address

Bethesda, MD, 20892